WednesdayJul 05, 2017 12:45 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Focused on the Science of Cannabinoids

Science-based cannabinoid pharmaceuticals are big market winners InMed Pharmaceuticals is developing two potential blockbuster drugs IMLFF has innovative and disruptive market advantages The market is rife with hype, pretenders and wannabes in the booming cannabis markets. In the rush to find the next hot cannabis stock, investors often overlook the real value in long-term scientific applications, and, after the heady hoopla of once-illicit marijuana dies down, those that chose science will be the ultimate winners. The medicinal and scientific applications of the 90 individual cannabinoid drugs found in cannabis are where the real value lies. Look no further than GW…

Continue Reading

WednesdayJul 05, 2017 9:41 am

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Employs Artificial Intelligence in Fight against Terrorism

Commercially developing a covert, disruptive solution using novel radar technology to detect concealed weapons—even on moving targets Market’s very first cost-effective answer to active shooter prevention Unsurpassed portable system developed through NATO-funded project at McMaster University Solution endorsed by Tom Ridge, first secretary of Homeland Security and current advisory board member Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) is employing cutting-edge machine learning/artificial intelligence technology in the global fight against terrorism. The company’s pioneering PATSCAN CMR™, which is the next-generation incarnation of its award-winning NForce CMR1000 software and radar solution, is a disruptive cognitive microwave radar system that is…

Continue Reading

WednesdayJul 05, 2017 8:54 am

Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is a Technology Disruptor for Edible Cannabinoids

First mover in plant-to-bloodstream niche Proprietary technology improving bioavailability of orally ingested cannabinoids Two distinct consumer product brands: ViPova™ and Lexaria Energy With the recreational market set for legalization on July 1, 2018, Canada’s cannabis industry is experiencing a high that is catalyzing innovation in the biosciences sector. Pioneering biopharmaceutical companies there and in other developed countries are working to develop a variety of healthful products based on their research into cannabinoids. As a result, investment capital flow to “plant-to-bloodstream” companies is expected to swell just as it has been doing for “seed-to-plant” companies for some time, and innovative British…

Continue Reading

Contact us: 212.418.1217